BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 666 found
  Current Search:  osteoporosi: 666     

HTML
100%
Test Your Knowledge Of Bone Health
Knowing key facts about bone health can help reduce the risk of osteoporosis, a disease that causes bones to become weak, brittle and prone to fracture.

Bone loss that leads to osteoporosis often can be slowed by: -- Getting...

Accessibility.com:  Jul 19 2008 4:59AM
Matching: osteoporosi
Find similar documents
HTML
100%
Health Tip: Risk Factors for Osteoporosis
(HealthDay News) Osteoporosis caused when the body can't replace bone calcium as fast as it is lost is common as people age, particularly among women.

More than 1.5 million Americans each year sustain a bone fracture related to ...

MedicineNet.com:  Jul 19 2008 11:04AM
Matching: osteoporosi
Find similar documents
HTML
100%
Lifetime Liquid D3 Targets Vitamin D Deficiencies in U.S. Population
Growing Awareness of Vitamin D Deficiencies Sparks Sharp Rise in Vitamin D Testing SCOTTSDALE, Ariz.-- (BUSINESS WIRE) -- Baywood International, Inc.

(OTCBB:BAYW) (Company) announced that three of the largest testing labs in the United...

SmartBrief:  Jul 19 2008 9:51AM
Matching: osteoporosi
Find similar documents
HTML
100%
Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offerin
BEDFORD, Mass.

The depositary for the offer has advised Hologic and the Purchaser that, as of the expiration of the initial offering period, a total of approximately 45,225,950 Third Wave shares were validly tendered to the Purchaser ...

DiGiTAL50:  Jul 19 2008 7:18AM
Matching: osteoporosi
Find similar documents
HTML
100%
Earnings Preview: Merck & Co. [XFNA]
WHITEHOUSE STATION, N.J.

(AP) - Merck & Co., the world's No.

8 drugmaker by sales, reports earnings for the second quarter on Monday morning.

The following is a summary of key developments and analyst opinion related to the...

Aastocks.com:  Jul 19 2008 2:02AM
Matching: osteoporosi
Find similar documents
HTML
100%
Israel's Teva buys drug rival for $7.5bn
The global leader in copycat drugs, Teva Pharmaceuticals, is taking over a US rival, Barr Pharmaceuticals, in a $7.5bn deal which continues a rapid spate of consolidation in the crowded industry for generic medicines.

The Israel-based...

Guardian Unlimited:  Jul 19 2008 1:28AM
Matching: osteoporosi
Find similar documents
HTML
100%
Israel's Teva buys US copycat drug rival for $7.5bn
The global leader in copycat drugs, Teva Pharmaceuticals, is taking over a US rival, Barr Pharmaceuticals, in a $7.5bn deal which continues a rapid spate of consolidation in the crowded industry for generic medicines.

The Israel-based...

Guardian Unlimited:  Jul 19 2008 12:51AM
Matching: osteoporosi
Find similar documents
HTML
100%
Galapagos Announces First Milestone in Osteoporosis Collaboration with Lilly
- Galapagos NV (Euronext: GLPG) announced today that it has reached the first milestone in its osteoporosis collaboration with Eli Lilly and Company (NYSE:LLY), triggering a payment of 1 million from Lilly.

In December 2007, Lilly...

Pharma Live:  Jul 18 2008 1:14PM
Matching: osteoporosi
Find similar documents
HTML
100%
Galapagos reaches first milestone in osteoporosis collaboration
Galapagos has reached the first milestone in its osteoporosis collaboration with Eli Lilly and Company, triggering a payment of E1 million from Lilly.In December 2007, Lilly and Galapagos initiated a program to develop new medicines...
Datamonitor:  Jul 18 2008 3:53PM
Matching: osteoporosi
Find similar documents
HTML
100%
Galapagos reaches first milestone in osteoporosis collaboration
Galapagos has reached the first milestone in its osteoporosis collaboration with Eli Lilly and Company, triggering a payment of E1 million from Lilly.In December 2007, Lilly and Galapagos initiated a program to develop new medicines...
Therapeutics Daily:  Jul 18 2008 12:16PM
Matching: osteoporosi
Find similar documents
HTML
100%
Galapagos announces first milestone in osteoporosis collaboration with Lilly
- Galapagos NV (Euronext: GLPG) announced today that it has reached the first milestone in its osteoporosis collaboration with Eli Lilly and Company (NYSE:LLY), triggering a payment of 1 million from Lilly.

In December 2007, Lilly...

Therapeutics Daily:  Jul 18 2008 11:34AM
Matching: osteoporosi
Find similar documents
HTML
100%
Tai Chi Helps Arthritis Patient
Cholesterol Screens For Kids Are Appropriate A group of some of the nation's leading doctors are issuing new guidelines for cholesterol screening and testing in kids, and with them comes a first-of-its kind recommendation that some high-risk...
R News:  Jul 18 2008 11:16AM
Matching: osteoporosi
Find similar documents
HTML
100%
Foolish Forecast: How Quickly Can Merck Turn It Around?
Merck (NYSE: MRK) has had a string of tough breaks this year.

We'll get a closer look at whether its turnaround is imminent when it releases earnings on the other side of the weekend, but until then, here's a preview of what to expect.

Motley Fool:  Jul 18 2008 8:54PM
Matching: osteoporosi
Find similar documents
HTML
100%
Research Australia: Finding that could shed light on 'golden staph,' candida and allergies
Finding that could shed light on 'golden staph,' candida and allergies (NewsRx.com) -- Recent scientific findings explain why patients with a rare immunodeficiency disorder are unusually susceptible to certain common infections.

By...

NewsRX:  Jul 18 2008 8:26PM
Matching: osteoporosi
Find similar documents
HTML
100%
Hosmat Hospital, Bangalore
The Hospital has added 100 beds last year making it a total of 450 beds, another four operation theaters were recently added and now the total operation theaters are 12.

This makes Hosmat Hospital an exclusive orthopaedic Hospital in India...

Express Healthcare Management:  Jul 18 2008 6:05AM
Matching: osteoporosi
Find similar documents
HTML
100%
Merck Victorious over Apotex in Fosamax Counterclaims Case
A Font Size: Print Merck & Co.

Apotex, No.

2007-1362 (Fed.

2008) Fosamax(alendronate sodium) is one of the all-time best-selling drugs for the treatment and prevention of osteoporosis, with over $3 billion in U.S.

sales...

Seeking Alpha:  Jul 18 2008 4:47AM
Matching: osteoporosi
Find similar documents
HTML
100%
Turning on hormone tap could aid osteoporosis fight
A potential new drug that 'opens the taps' for the release of useful hormones could stimulate new bone growth - and may eventually bring relief to osteoporosis sufferers.

The exciting potential of so-called 'negative allosteric...

News-Medical.Net:  Jul 17 2008 3:51AM
Matching: osteoporosi
Find similar documents
HTML
100%
Health Tip: Risk Factors for Osteoporosis
(HealthDay News) -- Osteoporosis -- caused when the body can't replace bone calcium as fast as it is lost -- is common as people age, particularly among women.

Health Tip: Risk Factors for Osteoporosis.

National Womens Health Information Center:  Jul 17 2008 6:21PM
Matching: osteoporosi
Find similar documents
HTML
100%
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Ad
DANBURY, Conn., July 16 /PRNewswire-FirstCall/ -- Biodel Inc.

today announced that its two pivotal Phase III VIAject(TM) clinical trials are now complete, with the last study patient visit on July 14, 2008.

Results of the full trial will...

KOTA Territory News:  Jul 17 2008 8:25AM
Matching: osteoporosi
Find similar documents
HTML
100%
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Ad
DANBURY, Conn., July 16 /PRNewswire-FirstCall/ -- Biodel Inc.

today announced that its two pivotal Phase III VIAject(TM) clinical trials are now complete, with the last study patient visit on July 14, 2008.

Results of the full trial will...

KLFY:  Jul 17 2008 12:43AM
Matching: osteoporosi
Find similar documents
HTML
100%
Discovery of a new signaling mechanism may lead to novel anti-inflammatory therapy
, 2:25 PM EST A team of researchers at the University of California, San Diego School of Medicine has uncovered a new signaling mechanism used to activate protein kinases that are critical for the body's inflammatory response.

Their work...

Genetic Engineering News:  Jul 17 2008 7:14PM
Matching: osteoporosi
Find similar documents
HTML
100%
Experts Clarify the Benefits and Risks of Hormone Therapy After Menopause
-- Updated clinical recommendations for hormone therapy (HT) for postmenopausal women based on the best available evidence have just been released by the North American Menopause Society (NAMS) and will appear in the July/August 2008 issue...
Doctors Guide:  Jul 17 2008 5:40PM
Matching: osteoporosi
Find similar documents
HTML
100%
Patient death GP action 'illegal'
Dr Iain Kerr has been accused of inappropriate conductA GP broke the law by prescribing sleeping pills to a patient who had talked of killing herself, a medical expert has said.Glasgow doctor Iain Kerr gave the medication to an 87-year-old...
BBC:  Jul 17 2008 5:30PM
Matching: osteoporosi
Find similar documents
HTML
100%
PRESS RELEASE Novartis Gains Momentum With -4- (DJ)
therapy for patients with cancer that has spread to the bones, was unchanged as fast expansion in some markets offset the US and Europe.

Growth for this class of medicines began to slow in 2007 with patients receiving treatment less...

Easy Bourse:  Jul 17 2008 7:05AM
Matching: osteoporosi
Find similar documents
HTML
100%
PRESS RELEASE Novartis Gains Momentum With -2- (DJ)
healthcare.

Net sales from continuing operations for the Group are expected to rise at a mid-single-digit rate, and at a low-single-digit growth rate in the Pharmaceuticals Division, both in local currencies.

Sandoz is now expected to...

Easy Bourse:  Jul 17 2008 7:05AM
Matching: osteoporosi
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.